Cochlear Limited operates in the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cochlear Limited with three other
medical equipment manufacturers in Australasia:
sales of 35.07 million Australian Dollars [US$27.04 million]
of which 43%
was Australia and Asia Pacific),
Mach7 Technologies Ltd
(18.86 million Australian Dollars [US$14.54 million]
of which 58%
was Software licenses), and
(100.05 million Australian Dollars [US$77.14 million]
of which 100%
was single operating segment).
During the second
quarter of 2021, sales at Cochlear Limited totalled
This is a drop of 1.7%
from the A$755.70 million in sales at the company during the second quarter in 2020.
Cochlear Limited reported sales of A$1.32 billion (US$1.02 billion)
June of 2020.
decrease of 7.4%
versus 2019, when the company's sales were A$1.43 billion.
Contributing to the drop in overall sales was the 7.6% decline
in Emea, from A$519.20 million to A$479.60 million.
There were also decreases in sales in
Americas (down 5.6% to A$650.30 million)
Asia Pacific (down 6.7% to A$222.40 million)